-
公开(公告)号:US20130023817A1
公开(公告)日:2013-01-24
申请号:US13628627
申请日:2012-09-27
IPC分类号: A61M37/00
CPC分类号: A61L29/08 , A61B17/320725 , A61B2017/320733 , A61L29/143 , A61L29/16 , A61L31/16 , A61L2300/216 , A61L2300/416 , A61L2300/606 , A61L2300/802 , A61M25/10 , A61M25/104 , A61M2025/105 , A61M2025/109
摘要: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one drug or drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein a combination of the at least one drug being a limus drug and the at least one lipophilic antioxidant being butylated hydroxytoluene is excluded.
摘要翻译: 本发明涉及评估或切割气球导管,其至少在其表面的一部分上携带至少一种药物或药物制剂和至少一种亲脂性抗氧化剂,其比例为至少一种亲脂性抗氧化剂的3-100重量% 相对于100重量%的药物,其中排除了至少一种药物和至少一种亲脂性抗氧化剂作为药物的组合,其中所述至少一种亲脂性抗氧化剂是丁基化羟基甲苯。
-
公开(公告)号:US20140188036A1
公开(公告)日:2014-07-03
申请号:US13975220
申请日:2013-08-23
CPC分类号: A61L29/08 , A61B17/320725 , A61B2017/320733 , A61L29/143 , A61L29/16 , A61L31/16 , A61L2300/216 , A61L2300/416 , A61L2300/606 , A61L2300/802 , A61M25/10 , A61M25/104 , A61M2025/105 , A61M2025/109
摘要: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.
-
公开(公告)号:US20130046237A1
公开(公告)日:2013-02-21
申请号:US13641941
申请日:2010-11-03
IPC分类号: A61M25/10
CPC分类号: A61L29/16 , A61L31/16 , A61L2300/416
摘要: The present invention is related to a medical device carrying at least on a portion of its surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiarectic acid, resveratrol and propyl gallate, and wherein scoring or cutting balloons as medical devices are excluded.
摘要翻译: 本发明涉及至少在其一部分表面上携带至少一种氧化不敏感药物或不含氧化物的无氧化物的药物制剂和至少一种亲脂性抗氧化剂,其比例为3-100重量% 所述至少一种抗氧化剂相对于所述药物的100重量%,其中所述至少一种氧化不敏感药物选自紫杉烷类,沙利度胺,他汀类,皮质激素和皮质激素的亲脂性衍生物,并且所述至少一种亲脂性抗氧化剂是 选择去甲二氢越南酸,白藜芦醇和没食子酸丙酯,并且其中排除作为医疗装置的评分或切割气球。
-
公开(公告)号:US20130338572A1
公开(公告)日:2013-12-19
申请号:US13975209
申请日:2013-08-23
IPC分类号: A61M25/10
CPC分类号: A61L29/08 , A61B17/320725 , A61B2017/320733 , A61L29/143 , A61L29/16 , A61L31/16 , A61L2300/216 , A61L2300/416 , A61L2300/606 , A61L2300/802 , A61M25/10 , A61M25/104 , A61M2025/105 , A61M2025/109
摘要: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.
摘要翻译: 本发明涉及评估或切割气球导管,其至少在其表面的一部分上携带至少一种氧化不敏感药物或不含氧化物的无氧化物的药物制剂和至少一种亲脂性抗氧化剂,其比例为3-100% 的至少一种亲脂性抗氧化剂相对于100重量%的药物,其中所述至少一种氧化不敏感药物选自紫杉烷类,沙利度胺,他汀类,皮质激素和皮质激素的亲脂性衍生物,并且所述至少一种 亲脂性抗氧化剂选自去甲二氢愈创木酸,白藜芦醇和没食子酸丙酯。
-
公开(公告)号:US09974888B2
公开(公告)日:2018-05-22
申请号:US13641941
申请日:2010-11-03
CPC分类号: A61L29/16 , A61L31/16 , A61L2300/416
摘要: The present invention is related to a medical device carrying at least on a portion of its surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiarectic acid, resveratrol and propyl gallate, and wherein scoring or cutting balloons as medical devices are excluded.
-
公开(公告)号:US20130046231A1
公开(公告)日:2013-02-21
申请号:US13628608
申请日:2012-09-27
IPC分类号: A61M25/10
CPC分类号: A61L29/08 , A61B17/320725 , A61B2017/320733 , A61L29/143 , A61L29/16 , A61L31/16 , A61L2300/216 , A61L2300/416 , A61L2300/606 , A61L2300/802 , A61M25/10 , A61M25/104 , A61M2025/105 , A61M2025/109
摘要: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.
-
-
-
-
-